JPS62123194A - Novel substance no.8345-c having plant growth retarding and antibiotic activity - Google Patents

Novel substance no.8345-c having plant growth retarding and antibiotic activity

Info

Publication number
JPS62123194A
JPS62123194A JP60263227A JP26322785A JPS62123194A JP S62123194 A JPS62123194 A JP S62123194A JP 60263227 A JP60263227 A JP 60263227A JP 26322785 A JP26322785 A JP 26322785A JP S62123194 A JPS62123194 A JP S62123194A
Authority
JP
Japan
Prior art keywords
methanol
spectrum
plant growth
soluble
magnetic resonance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60263227A
Other languages
Japanese (ja)
Other versions
JPH0474357B2 (en
Inventor
Takao Kida
隆夫 木田
Hiroshiro Shibai
柴井 博四郎
Haruo Seto
治男 瀬戸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP60263227A priority Critical patent/JPS62123194A/en
Publication of JPS62123194A publication Critical patent/JPS62123194A/en
Publication of JPH0474357B2 publication Critical patent/JPH0474357B2/ja
Granted legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

NEW MATERIAL:An antibiotic No.8345-C. External appearance: white needle crystal; elementary analysis (%): C, 63.0; H, 7.5; N, 4.1. molecular weight, 323. molecular formula; C17H25NO5. specific rotatory power: [alpha]D<24>+17.3 deg. (C 0.075, methanol) melting point; 212-214 deg.C. solubility; soluble in water. color reaction; positive to potassium permanganate and negative to ninhydrin. USE:An antimicrobial agent, agricultural chemical, etc., having antimicrobial activity and plant growth retarding activity. PREPARATION:Perenisporia medullaepanis AJ8345 (FERM-P No.8181) strain is cultivated, preferably in a liquid medium at 6.0-8.0pH and 20-35 deg.C under an aerobic condition by a spinner culture method with aeration.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は、新規物質& 8’345− Cに関する。こ
の物質は、植物生長抑制活性及び抗生物質活性金有し、
農薬及び医薬の分野で利用される。
DETAILED DESCRIPTION OF THE INVENTION (Industrial Application Field) The present invention relates to a novel substance &8'345-C. This substance has plant growth inhibitory activity and antibiotic activity,
Used in the agricultural and pharmaceutical fields.

(従来の技術) 従来より知られている抗生物質作用と、植物生長抑制作
用を併せ持つ物質としては、シクロヘキシミド(特公昭
45−22754) 、アニソマイシン。
(Prior Art) Conventionally known substances having both antibiotic action and plant growth inhibitory action include cycloheximide (Japanese Patent Publication No. 45-22754) and anisomycin.

トヨカマイシン(Agric、 Biol、 Chem
、、 36.2013(1970) ) 、 ハービマ
イシンA 、 13 (J、 Antibiot、。
Toyocamycin (Agric, Biol, Chem
, 36.2013 (1970)), Herbimycin A, 13 (J, Antibiot,.

29、863 (1976) ) 、 ハービマイシン
(J、 Antibiot、。
29, 863 (1976)), Herbimycin (J. Antibiot.

32、255 (1979) )サイトバリシン(第5
回国際農薬学会講演要旨、I[b−3,1982)、ビ
アラホス(第5回国際農薬学会講演要旨、 ■a−19
,1982)などが知られており、このうち、ビアラホ
スが除草剤として実用化されている。
32, 255 (1979)) Cytovaricin (No. 5
Abstracts of the 5th International Pesticide Conference, I [b-3, 1982), Bialajos (Summary of the 5th International Pesticide Conference, ■a-19
, 1982), among which bialaphos has been put into practical use as a herbicide.

又、担子菌の生産する抗生物質としてはポリアセチレン
化合物、テルペノイド化合物、芳香族化合物、核酸アナ
ログなど(発酵と工業+ Vo l −34+A11P
843)の他、非蛋白性アミノ酸が知られている(化学
と生物14,205(1976)が、これらの物質の植
物生長抑制作用に関する報告例は無い。
In addition, antibiotics produced by basidiomycetes include polyacetylene compounds, terpenoid compounds, aromatic compounds, and nucleic acid analogs (Fermentation and Industry + Vol-34 + A11P
843) and other non-protein amino acids are known (Chemistry and Biology 14, 205 (1976)), but there are no reports on the plant growth inhibitory effects of these substances.

(本発明が解決しようとする問題点) 本発明が解決しようとする問題点は、新規で有用な植物
生長抑制作用と抗生物質作用を併せ持つ物質を提供する
ことにある。
(Problems to be Solved by the Present Invention) The problems to be solved by the present invention are to provide a novel and useful substance that has both plant growth inhibiting action and antibiotic action.

(問題点を解決するための手段) 本発明者らは、上述の問題点を解決するために新規な植
物生長抑制作用と抗生物質作用を併せ持つ物質の探索全
目的として、多数の担子菌の培養U’e探累した結果、
被しニポリア属(Pereniporia)に属する菌
株の菌糸のメタノール抽出物中に、Davisの最小培
地でバチルス・ズブチリス(Bacillus 5ub
tilis) AJ1316の生育阻害作用金有し、同
時に植物の生長を抑制する物質であるA3345− C
が生産されていることを見出した。そして、この有効物
質全培養液から純粋に単離し、理化学的性質を調べ、既
知物質との比較検討を行った結果、 屋8345− C
は、理化学的性質において、既知物質と異なっているこ
とを見出した。
(Means for Solving the Problems) In order to solve the above-mentioned problems, the present inventors cultivated a large number of basidiomycetes for the purpose of searching for a novel substance that has both plant growth inhibitory action and antibiotic action. As a result of U'e search,
Bacillus subtilis was cultured in a methanolic extract of mycelia of a strain belonging to the genus Pereniporia in Davis's minimal medium.
A3345-C, a substance that has the growth inhibitory effect of AJ1316 (AJ1316) and at the same time inhibits plant growth.
was found to be produced. Then, as a result of pure isolation of this effective substance from the total culture solution, investigation of its physical and chemical properties, and comparative study with known substances, it was found that 8345-C
discovered that it differs from known substances in its physical and chemical properties.

本発明は、これらの知見に基づいてなされたものである
The present invention has been made based on these findings.

なお、本発明者らは、先に、Pereniporiam
sdullaepanls AJ8345株の生産する
新規抗生物質A 8345− A 、 Bを出願してい
る(特願昭60−125498 。
Note that the present inventors previously discovered Pereniporium
An application has been filed for new antibiotics A8345-A and B produced by S. sdullaepanls AJ8345 strain (Japanese Patent Application No. 125498-1983).

特願昭60−163657 )。Patent application No. 163657/1983).

本発明の48345− Cはペレニポリア(Peren
i−poria )属に属する担子菌により生産される
。その−例として挙げられるベレニポリア・メデーラエ
ノ9ニス(Pereniporta m@dullae
panis ) AJ8345゜FERM−P8181
 (以下AJ8345菌という。)は、本発明の483
45− Ck有利に生産する特性を有している。
48345-C of the present invention is derived from Pereniporia (Pereniporia).
It is produced by basidiomycetes belonging to the genus I-poria). An example of this is Pereniporta m@dullae.
panis) AJ8345°FERM-P8181
(hereinafter referred to as AJ8345 bacterium) is the 483 bacterium of the present invention.
45-Ck has advantageous production properties.

本発明のA 8345− C全得るには、イレニポリア
属に属するA 8345− C生産菌を、本物質を生産
する通常の方法で培養することが出来る。工業的に有利
に生産するには、A 8345− C生産菌を好気的条
件下で各種栄養物質を含む培地で通気攪拌培養を行えば
よ(へ。
In order to obtain the whole A 8345-C of the present invention, A 8345-C producing bacteria belonging to the genus Illeniporia can be cultured by a conventional method for producing this substance. For industrially advantageous production, A 8345-C producing bacteria can be cultured under aerobic conditions with aeration in a medium containing various nutrients.

培養条件および培地の組成は、一般の担子菌が生育する
ものであればよい。すなわち培地は原則として炭素源、
窒素源、無機塩全音み、必要に応じて、ビタミン類、先
駆物質などを加えても良い。
The culture conditions and the composition of the medium may be those that allow general basidiomycetes to grow. In other words, the medium is basically a carbon source,
A nitrogen source, an inorganic salt, and if necessary, vitamins, precursors, etc. may be added.

炭素源としては、例えば、グルコース、アラビノース、
キシロース、澱粉、デキストリン、グリセリン、マンニ
トール、有機酸、糖蜜、馬鈴薯などが、単独で又は、混
合物として使用され、窒素源としては、例えばペプトン
、大豆粉、コーン・スチーゾ・リカー、麦芽抽出物、ア
ミノ酸、米糠、麦芽、尿素、アンモニウム塩など又はこ
れらの混合物が用いられる。又必要に応じて、シリコー
ン油、大豆油、界面活性剤等の消泡剤を加えても良い。
Examples of carbon sources include glucose, arabinose,
Xylose, starch, dextrin, glycerin, mannitol, organic acids, molasses, potato, etc. are used alone or in mixtures, and nitrogen sources include, for example, peptone, soybean flour, corn stizo liquor, malt extract, amino acids. , rice bran, malt, urea, ammonium salt, etc., or a mixture thereof. Further, if necessary, an antifoaming agent such as silicone oil, soybean oil, or surfactant may be added.

培地は液体培地が好ましく、培地の…は約6.0〜約8
.0が良く、培養温度は、約20〜約35℃に調節する
のが良い。
The medium is preferably a liquid medium, and the ... of the medium is about 6.0 to about 8.
.. The culture temperature is preferably adjusted to about 20 to about 35°C.

培養終了後、培養物からA 8345− Cを分離、採
取する方法は、通常の発酵生産物を培養物から分離採取
する方法に準じて行えば良い。すなわち、各種有機溶媒
による抽出法、各種活性吸着剤によるクロマトグラフィ
ーなどを適宜組み合せて、洗8345− Cを採取する
After completion of the culture, A 8345-C may be separated and collected from the culture in accordance with a conventional method for separating and collecting fermentation products from the culture. That is, Wash 8345-C is collected by appropriately combining extraction methods using various organic solvents, chromatography using various active adsorbents, and the like.

次に実施例に上りA 8345− Cの製造例を示すが
本実施例は、本発明の範囲をなんら限定するものではな
い。
Next, a manufacturing example of A 8345-C will be shown as an example, but this example is not intended to limit the scope of the present invention in any way.

実施例I A 8345− Cの製造ならびに構造解析ポテト・デ
キストロース寒天斜面に生育したAJ8345菌を可溶
性デンプン1%、グルコース2%、硫酸アンモニウム0
.5%、リン酸第−カリウム0.05%、硫酸マグネシ
ウム0.05%、塩化ナトリウム0.05%、ポテトエ
キス70 El/l 、微量金属” 1 m、l/lの
割合で含む発酵培地(500d容坂ロフラスコに100
mJずつ分注)に植菌し、27℃で20〜30日間振盪
又は、静置培養した。
Example I Production and structural analysis of A 8345-C AJ8345 bacteria grown on potato dextrose agar slopes were treated with 1% soluble starch, 2% glucose, and 0 ammonium sulfate.
.. 5%, potassium phosphate 0.05%, magnesium sulfate 0.05%, sodium chloride 0.05%, potato extract 70 El/l, trace metals 1 m, l/l fermentation medium ( 100 to 500d Yosakaro flask
The cells were inoculated into a microorganism (dispensed in mJ aliquots) and cultured at 27° C. for 20 to 30 days with shaking or static culture.

中微量金属 CuSO4’5H200,64,9 FaSO4’7H200,11g MnC12’4H200,79g ZnSO4’7H200,151 蒸留水     100m1 得られた培養061から、ろ過により、菌体を集め、2
1のメタノールで2回抽出し、メタノール溶液を減圧濃
縮、乾固した後、少量のメタノールに溶解させた。次に
シリカダルカラムクロマトグラフィー(ローパーカラム
Si 60 、サイズB、メルク社製)により精製した
。展開溶媒はメタノール−酢酸エチル(5:95)を用
いた。活性区分を集め、減圧濃縮乾固の後、少量のメタ
ノールに溶解し、5ephadex LH−20k用い
たダルクロマトグラフィーにより精製した(カラム容積
30M)。
Medium trace metal CuSO4'5H200,64,9 FaSO4'7H200,11g MnC12'4H200,79g ZnSO4'7H200,151 Distilled water 100ml From the obtained culture 061, collect bacterial cells by filtration,
1 was extracted twice with methanol, and the methanol solution was concentrated under reduced pressure to dryness, and then dissolved in a small amount of methanol. Next, it was purified by silica dull column chromatography (Roper column Si 60, size B, manufactured by Merck & Co.). Methanol-ethyl acetate (5:95) was used as the developing solvent. The active fractions were collected, concentrated to dryness under reduced pressure, dissolved in a small amount of methanol, and purified by Dal chromatography using 5ephadex LH-20k (column volume: 30M).

展開には、メタノールを用いた。活性区分を集め、減圧
濃縮後、セミ分取用μBondapak Cl8(登録
商標1日本ウォータース製)カラムを用いたHPLCに
より、活性成分の精製・単離を行った。移動相には、3
0 % CH,CN水溶液を用いた。保持時間約40分
に、A 8345− Cを分取した。末法により、最終
的に61の培養液から、A 8345− Cを約5mq
単離した。
Methanol was used for development. The active fraction was collected and concentrated under reduced pressure, and then the active component was purified and isolated by HPLC using a semi-preparative μBondapak Cl8 (registered trademark 1 manufactured by Nippon Waters) column. The mobile phase contains 3
A 0% CH,CN aqueous solution was used. At a retention time of approximately 40 minutes, A 8345-C was collected. By the final method, approximately 5 mq of A 8345-C was finally obtained from the culture solution of 61.
isolated.

この様にして得られた抗生物質A 8345− Cは、
以下に述べるとおりの理化学的性質を有する。
The antibiotic A 8345-C obtained in this way is
It has the physical and chemical properties described below.

(1)外観:白色針状結晶 (2)元素分析値:炭素63.0%、水素7.5%、窒
素4.1%(重量比) (3)分子址:高分解能EI−MS m/z : 32
3.17327(M+) (4)分子式:C47H25NO5 (5)  比旋光度;〔α]、 +17.3°(C0.
075、メタノール) (6)融点:212〜214℃ (力 溶解性:メタノール、酢酸エチルに可溶。
(1) Appearance: White needle-like crystals (2) Elemental analysis values: Carbon 63.0%, Hydrogen 7.5%, Nitrogen 4.1% (weight ratio) (3) Molecular composition: High resolution EI-MS m/ z: 32
3.17327 (M+) (4) Molecular formula: C47H25NO5 (5) Specific optical rotation: [α], +17.3° (C0.
075, methanol) (6) Melting point: 212-214°C (Solubility: Soluble in methanol and ethyl acetate.

水洗わずかに溶ける。Dissolves slightly when washed with water.

(8)紫外部吸収ス被り′トル:Uv)、Me0Hnm
=211(9)赤外部吸収スペクトル:臭化カリウム錠
剤で測定したスペクトルは、第1図に示す通り。
(8) Ultraviolet absorption spectrum (Uv), Me0Hnm
=211 (9) Infrared absorption spectrum: The spectrum measured with potassium bromide tablets is as shown in FIG.

QO)  水素核磁気共鳴スペクトル:重メタノール中
で測定したス被りトルは、第2図に示す通り。
QO) Hydrogen nuclear magnetic resonance spectrum: The coverage measured in heavy methanol is as shown in Figure 2.

Uυ 炭素核磁気共鳴スペクトル:重メタノール中で測
定したスペクトルは、第3図に示す通り。
Uυ carbon nuclear magnetic resonance spectrum: The spectrum measured in heavy methanol is as shown in Figure 3.

α力 呈色反応:過マンガン酸カリ陽性、ニンヒドリン
陰性 高分解能のEI−MS m/z : 323.1732
7より分子式C47H25NO5が導かれた。更に紫外
部吸収スペクトル(UVλ二号211 nm )、赤外
部吸収スペクトル(IRV、’::rc1730 、1
720 、1680 cm−’ )のデータより、分子
内にα、β−不飽和r−ラクトン数は、22個である(
第−表)。従って、残りの交換性のプロトンの数は3個
である。これらは。
α power Color reaction: Potassium permanganate positive, ninhydrin negative High resolution EI-MS m/z: 323.1732
7, the molecular formula C47H25NO5 was derived. Furthermore, ultraviolet absorption spectrum (UVλ2 211 nm), infrared absorption spectrum (IRV, '::rc1730, 1
720, 1680 cm-'), the number of α, β-unsaturated r-lactones in the molecule is 22 (
Table 1). Therefore, the number of remaining exchangeable protons is three. these are.

酸素原子又は窒素原子に結合していると考えられ−oc
cH3(δc173.4)の存在が知られ、又、ニンヒ
ドリン陰性と、先の赤外部吸収スペクトルのデータより
導かれた一C−NH=の部分構造を加え、3個の交換性
のプロトンは、窒素原子に1個、残りの2個は、酸素原
子に−OHとして結合すると考えられる。
It is thought that it is bonded to an oxygen atom or a nitrogen atom -oc
The existence of cH3 (δc173.4) is known, and by adding the ninhydrin negativity and the partial structure of 1C-NH= derived from the above infrared absorption spectrum data, the three exchangeable protons are It is thought that one bond is bonded to the nitrogen atom and the remaining two bond to the oxygen atom as -OH.

一方分子式から計算した不飽和数は、5で、二重結合1
個と、 C=Oを1個含むことより、二環性の化合物で
ある。更に、’H,”C−NMRスペクトル−CI−1
2−CH2−CH2−を含むことも合せて1本化合物を
drimane flの骨格e有するセスキテルペン系
ノ化合物と推定した。以上の理化学的性質を有する化合
物は、他に該当する物は無<−A8345−Cば、新規
物質である。
On the other hand, the number of unsaturations calculated from the molecular formula is 5, and the double bond is 1.
Since it contains one C=O, it is a bicyclic compound. Furthermore, 'H,'C-NMR spectrum-CI-1
In addition to containing 2-CH2-CH2-, this compound was estimated to be a sesquiterpene compound having the skeleton e of drimane fl. A compound having the above physical and chemical properties is a new substance if there are no other applicable substances.

第−表 A 8345− Cの13C−NMRスペクト
ルデータケミカルシフト 13Cpeak   (ppm)  K 子団’HA 
       19.6    −CH2−g、IB 
      21.4−CH3」 (12)1,7−CH5f D       23.6−CH5b E        33.8    − CH3aF 
         34.4     −C−G   
   37.1    タC−H37,9−CH2−c
 、 k l       44.3    −CH2−d 、 
eJ       50.2     ′:/cH−h
K       64.8     ;CH−0−IL
       74.5     ’)SH−0−mM
       78.2     ;CH−0−nN 
     144.2     ;(:=0     
151.1     ’):、c=P      17
2.1     ン=OQ      173.4  
   ンc=。
Table A 13C-NMR spectrum data of 8345-C Chemical shift 13Cpeak (ppm) K Group'HA
19.6 -CH2-g, IB
21.4-CH3" (12) 1,7-CH5f D 23.6-CH5b E 33.8-CH3aF
34.4 -C-G
37.1 TaC-H37,9-CH2-c
, k l 44.3 -CH2-d,
eJ 50.2':/cH-h
K 64.8; CH-0-IL
74.5') SH-0-mM
78.2 ;CH-0-nN
144.2 ;(:=0
151.1'):, c=P 17
2.1 N=OQ 173.4
c=.

次元NMRスペクトルデータより行った。This was done using dimensional NMR spectrum data.

実施例2 A 8345− Cの生物活性 抗生物質A 8345− Cは、第二表に示した組成の
Davisの最小培地で、バチルス属の細菌の生育阻止
作用を示し、これにポリペプトン、酵母エキスを添加し
た培地では、生育阻止作用を示さなかった。その代表的
な菌株に対する最小阻止濃度(MIC)は、第三表の通
りである。
Example 2 Biological activity of A 8345-C Antibiotic A 8345-C exhibits growth inhibiting effect on Bacillus bacteria in Davis's minimal medium having the composition shown in Table 2. The added medium did not show any growth inhibiting effect. The minimum inhibitory concentrations (MIC) for typical bacterial strains are shown in Table 3.

第二表 PH7,0 更に、A 8345− Cは、植物の生長を抑制する作
用を有し、特に、レタス及び食用と二の種子発芽の際、
根部の伸長を阻害した。詳細は第四表の通りである。
Table 2 PH7,0 Furthermore, A 8345-C has the effect of suppressing the growth of plants, especially during the germination of lettuce and edible seeds.
Inhibited root elongation. Details are shown in Table 4.

屋8345− Cの生物活性 第三表 抗菌活性 Escherichia colt JC−2AJ20
05  >50  >50Sarcina 1utea
 AJ1217     12.5  )50Xant
homonas oryzae AJ2783    
)50  >50Bacillus 5ubtilis
 AJ1316   1.56  )50Bacill
us ceraus AJ11252    1.56
  )50培地l、  [)avis最小培地 培地2、1)avis最小培地+0.2係ポリペプトン
、0.1%酵母エキス 第四表 植物生長抑制作用 生育(無処理区に対するチ)
Table 3 Biological activity of Ya8345-C Antibacterial activity Escherichia colt JC-2AJ20
05 >50 >50 Sarcina 1utea
AJ1217 12.5) 50Xant
homonas oryzae AJ2783
)50 >50Bacillus 5ubtilis
AJ1316 1.56) 50Bacill
us ceraus AJ11252 1.56
) 50 liters of medium, [) Avis minimal medium 2, 1) Avis minimal medium + 0.2 polypeptone, 0.1% yeast extract Table 4 Plant growth inhibitory effect Growth (compared to untreated plot)

【図面の簡単な説明】[Brief explanation of drawings]

第1図は& 8345− Cの臭化カリウム錠剤中で測
定した光外部吸収スペクトルである。 第2図はA 8345− Cの重メタノール中で測定し
た水素核出気共鳴スペクトルである。 第3図はA 8345− Cの重メタノール中で測定し
た炭素核磁気共鳴スペクトルである。 第4図はA 8345− Cの重メタノール中で測定し
たH−Cンフト相関二次元核磁気共鳴スペクトルである
。 41,1、出゛、、・ノ(弓9.・’:、’、’!4.
八二、゛i手続補正!! (方式) 持訂庁良宮殿 2、発明の名称 植物1艮抑υノ活性及び抗生物質活(’lをイiする新
規物!No、8345−C 住所   東京都中央区京(ニー丁目5番8弓(発送日
     nq和61イ[2025日)5、補正にJ、
り増加づる発明の故   なし8、添付店類の目録 訂正願書      1通
FIG. 1 is an optical external absorption spectrum measured in a potassium bromide tablet of &8345-C. FIG. 2 is a hydrogen nuclear outgas resonance spectrum of A 8345-C measured in heavy methanol. FIG. 3 is a carbon nuclear magnetic resonance spectrum of A 8345-C measured in heavy methanol. FIG. 4 is an H-C Nft correlation two-dimensional nuclear magnetic resonance spectrum of A 8345-C measured in heavy methanol. 41,1, Out,,・ノ(Bow 9.・':,','!4.
82, ゛i procedure amendment! ! (Method) Revision Office Liangmiya 2, Name of the invention Plant 1 A new product with inhibitory activity and antibiotic activity! No. 8345-C Address 5, Kyo (Nee-chome), Chuo-ku, Tokyo 8 bow (shipment date nqwa61i [2025th) 5, correction J,
No. 8 due to an increase in the number of inventions, attached 1 copy of application for correction of inventory of stores etc.

Claims (1)

【特許請求の範囲】 1、下記の理化学的性質を有することを特徴とする新規
物質No.8345−C (1)外観:白色針状結晶 (2)元素分析値:炭素63.0%、水素7.5%、窒
素4.1%(重量比) (3)分子量:EI−MSm/z:323(M^+)(
4)分子式:C_1_7H_2_5NO_5(高分解能
EI−MSm/z:323.17327より) (5)比旋光度:〔α〕^2^4_D+17.3°(C
0.075、メタノール) (6)融点:212〜214℃ (7)溶解性:メタノール、酢酸エチルに可溶、水にわ
ずかに溶ける。 (8)紫外部吸収スペクトル:UVλ^M^e^O^H
_m_a_xnm:211(9)赤外部吸収スペクトル
:臭化カリウム錠剤で測定したスペクトルは第1図に示
す通り。 (10)水素核磁気共鳴スペクトル:重メタノール中で
測定したスペクトルは、第2図に示す通り。 (11)炭素核磁気共鳴スペクトル:重メタノール中で
測定したスペクトルは、第3図に示す通り。 (12)呈色反応:過マンガン酸カリ陽性、ニンヒドリ
ン陰性。
[Claims] 1. New substance No. 1 characterized by having the following physical and chemical properties. 8345-C (1) Appearance: White needle-like crystals (2) Elemental analysis values: Carbon 63.0%, Hydrogen 7.5%, Nitrogen 4.1% (weight ratio) (3) Molecular weight: EI-MSm/z :323(M^+)(
4) Molecular formula: C_1_7H_2_5NO_5 (from high resolution EI-MSm/z: 323.17327) (5) Specific optical rotation: [α]^2^4_D+17.3° (C
0.075, methanol) (6) Melting point: 212-214°C (7) Solubility: Soluble in methanol and ethyl acetate, slightly soluble in water. (8) Ultraviolet absorption spectrum: UVλ^M^e^O^H
_m_a_xnm: 211 (9) Infrared absorption spectrum: The spectrum measured with potassium bromide tablets is as shown in FIG. (10) Hydrogen nuclear magnetic resonance spectrum: The spectrum measured in heavy methanol is as shown in FIG. (11) Carbon nuclear magnetic resonance spectrum: The spectrum measured in heavy methanol is as shown in FIG. (12) Color reaction: Potassium permanganate positive, ninhydrin negative.
JP60263227A 1985-11-22 1985-11-22 Novel substance no.8345-c having plant growth retarding and antibiotic activity Granted JPS62123194A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60263227A JPS62123194A (en) 1985-11-22 1985-11-22 Novel substance no.8345-c having plant growth retarding and antibiotic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60263227A JPS62123194A (en) 1985-11-22 1985-11-22 Novel substance no.8345-c having plant growth retarding and antibiotic activity

Publications (2)

Publication Number Publication Date
JPS62123194A true JPS62123194A (en) 1987-06-04
JPH0474357B2 JPH0474357B2 (en) 1992-11-26

Family

ID=17386544

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60263227A Granted JPS62123194A (en) 1985-11-22 1985-11-22 Novel substance no.8345-c having plant growth retarding and antibiotic activity

Country Status (1)

Country Link
JP (1) JPS62123194A (en)

Also Published As

Publication number Publication date
JPH0474357B2 (en) 1992-11-26

Similar Documents

Publication Publication Date Title
PETERSEN et al. Production of cladospirone bisepoxide, a new fungal metabolite
JPS62123194A (en) Novel substance no.8345-c having plant growth retarding and antibiotic activity
JPH0226957B2 (en)
US5233062A (en) Antibiotic eicosenoic acids
JPS61282087A (en) Novel substance no.8345-a
JP2764759B2 (en) Novel substance BT-38 substance, method for producing the same and antifungal agent containing the same as an active ingredient
JPH0120153B2 (en)
US3555075A (en) Novel antifungal agents
JPS5918037B2 (en) New physiologically active substance anthglutin and its production method
JP3030896B2 (en) WB968 substance group and production method thereof
JPH01110653A (en) Fungicidal fermentation product and composition
KR970001001B1 (en) Method for manufacturing 1-deoxymannojirimycin
JP2849460B2 (en) Novel compound A-70615 substance and production method thereof
JP3068700B2 (en) Novel trehazolin derivatives and their production
JPS60218396A (en) Antibiotic do-248-a and do-248-b and preparation thereof
JPS6222594A (en) Novel substance no. 8345-b
JPS589676B2 (en) Nojirimycin B
JP2005220040A (en) New antifungal agent fa200b
JP2990628B2 (en) New plant growth regulating substance aji-302 and its production
JPH05255184A (en) New compound ilicicolinic acid a or b
FR2540116A1 (en) NOVEL ANTIBIOTIC AND ANTITUMORAL, LUZOPEPTIN E2, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS USING THE ANTIBIOTIC
JPS59166094A (en) Preparation of physiologically active substance ml-236b
JPH0525160A (en) Antimycotic substance mer-wf 5027-11
CH359700A (en) Process for preparing 1,4-pregnadienes
JPS6112916B2 (en)